Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors von Ashkar, Ryan, Feldman, Darren R., Adra, Nabil, Zaid, Mohammad Abu, Funt, Samuel A., Althouse, Sandra K., Perkins, Susan M., Snow, Christin I., Lazzara, Kayla M., Sego, Lina M., Quinn, David I., Hanna, Nasser H., Einhorn, Lawrence H., Albany, Costantine

Volltext

Immunomodulation by HDAC inhibition: Results from a phase I study with entinostat in combination with atezolizumab and bevacizumab in metastatic renal cell carcinoma patients von Pili, Roberto, Adra, Nabil, Damayanti, Nur, Logan, Theodore F., Narayan, Vivek, Monk, Paul, Dropcho, S, Sego, Lina M, Liu, Hao, Althouse, Sandra K., Haas, Naomi B.

Volltext

Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy von Albany, Costantine, Dockter, Travis, Wolfe, Eric G, Pachman, Deirdre R., Wagner-Johnston, Nina D., Lazzara, Kayla Marie, Sego, Lina M, Edwards, Sara I, Snow, Christin I, Hanna, Nasser, Einhorn, Lawrence, Loprinzi, Charles L., Costello, Brian Addis

Volltext